Selinexor 20 MG Clinical Trials

1 actively recruiting trial

Also known as: KPT-330

Pipeline

Phase 2: 1

Top Sponsors

Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas1

Indications

Sarcoma,Soft Tissue1
Cancer1

Other1 trial

Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.